{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:54:26Z","timestamp":1794693266710,"version":"4.9.1"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.pharmthera.2023.108436","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:27:08Z","timestamp":1683304028000},"page":"108436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Dysregulation of metabolic pathways in pulmonary fibrosis"],"prefix":"10.1016","volume":"246","author":[{"given":"Rishi","family":"Rajesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"B\u00e4rnthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2023.108436_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mito.2018.02.009","article-title":"Mitochondrial \u03b2-oxidation of saturated fatty acids in humans","volume":"46","author":"Adeva-Andany","year":"2019","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0010","doi-asserted-by":"crossref","first-page":"e158100","DOI":"10.1172\/jci.insight.158100","article-title":"microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis","author":"Ahangari","year":"2023","journal-title":"JCI Insight.8"},{"issue":"6060","key":"10.1016\/j.pharmthera.2023.108436_bb0015","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses","volume":"334","author":"Anastasiou","year":"2011","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108436_bb0020","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1096\/fj.201600428R","article-title":"Profibrotic up-regulation of glucose transporter 1 by TGF-beta involves activation of MEK and mammalian target of rapamycin complex 2 pathways","volume":"30","author":"Andrianifahanana","year":"2016","journal-title":"The FASEB Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168676","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis","volume":"77","author":"Aoki","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","article-title":"The role of TIMPs in regulation of extracellular matrix proteolysis","volume":"44-46","author":"Arpino","year":"2015","journal-title":"Matrix Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1165\/rcmb.2004-0383OC","article-title":"B lymphocytes are critical for lung fibrosis control and prostaglandin E2 regulation in IL-9 transgenic mice","volume":"34","author":"Arras","year":"2006","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0040","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1165\/rcmb.2018-0180OC","article-title":"Glutaminolysis epigenetically regulates antiapoptotic gene expression in idiopathic pulmonary fibrosis fibroblasts","volume":"60","author":"Bai","year":"2019","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0050","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1038\/s41598-017-08228-y","article-title":"The Role of PGE2 in alveolar epithelial and lung microvascular endothelial crosstalk","volume":"7","author":"B\u00e4rnthaler","year":"2017","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0055","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2019.11.032","article-title":"Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue","volume":"145","author":"Barnthaler","year":"2020","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108436_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7080201","article-title":"Idiopathic pulmonary fibrosis (IPF): an overview","volume":"7","author":"Barratt","year":"2018","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.155.1.9001319","article-title":"Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis","volume":"155","author":"Baumgartner","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0070","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1074\/jbc.RA117.000444","article-title":"Glutaminolysis is required for transforming growth factor-\u03b21-induced myofibroblast differentiation and activation","volume":"293","author":"Bernard","year":"2018","journal-title":"The Journal of Biological Chemistry"},{"issue":"42","key":"10.1016\/j.pharmthera.2023.108436_bb0075","doi-asserted-by":"crossref","first-page":"25427","DOI":"10.1074\/jbc.M115.646984","article-title":"Metabolic reprogramming is required for myofibroblast contractility and differentiation","volume":"290","author":"Bernard","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0080","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.imbio.2012.05.020","article-title":"Differential role of regulatory T cells in early and late stages of pulmonary fibrosis","volume":"218","author":"Boveda-Ruiz","year":"2013","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0085","doi-asserted-by":"crossref","first-page":"L1146","DOI":"10.1152\/ajplung.00383.2004","article-title":"PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis","volume":"288","author":"Burgess","year":"2005","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071209","article-title":"Extracellular lipids in the lung and their role in pulmonary fibrosis","volume":"11","author":"Burgy","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0095","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/thoraxjnl-2015-207020","article-title":"Pulmonary macrophages: key players in the innate defence of the airways","volume":"70","author":"Byrne","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biocel.2016.06.013","article-title":"Pigment epithelium-derived factor stimulates skeletal muscle glycolytic activity through NADPH oxidase-dependent reactive oxygen species production","volume":"78","author":"Carnagarin","year":"2016","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"33","key":"10.1016\/j.pharmthera.2023.108436_bb0105","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"1663-9812 (Print)","key":"10.1016\/j.pharmthera.2023.108436_bb0110","article-title":"Anlotinib inhibits PFKFB3-driven glycolysis in myofibroblasts to reverse pulmonary fibrosis","volume":"12","author":"Chen","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1165\/rcmb.2016-0225OC","article-title":"Glucose transporter 1-dependent glycolysis is increased during aging-related lung fibrosis, and phloretin inhibits lung fibrosis","volume":"56","author":"Cho","year":"2017","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","article-title":"Lysophospholipids and their receptors in the central nervous system","volume":"1831","author":"Choi","year":"2013","journal-title":"Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0125","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1096\/fj.202000564R","article-title":"SIRT7-mediated modulation of glutaminase 1 regulates TGF-beta-induced pulmonary fibrosis","volume":"34","author":"Choudhury","year":"2020","journal-title":"The FASEB Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40265-014-0233-5","article-title":"Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease","volume":"74","author":"Chrusciel","year":"2014","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2353\/ajpath.2007.060352","article-title":"Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis","volume":"170","author":"Chua","year":"2007","journal-title":"The American Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0140","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41467-019-11327-1","article-title":"Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis","volume":"10","author":"Chung","year":"2019","journal-title":"Nature Communications"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108436_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132095","article-title":"Regeneration or repair? The role of alveolar epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis (IPF)","volume":"11","author":"Confalonieri","year":"2022","journal-title":"Cells"},{"issue":"30","key":"10.1016\/j.pharmthera.2023.108436_bb0150","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.18632\/oncotarget.17114","article-title":"The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis","volume":"8","author":"Conforti","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-8935-5-15","article-title":"Deacetylation of H4-K16Ac and heterochromatin assembly in senescence","volume":"5","author":"Contrepois","year":"2012","journal-title":"Epigenetics & Chromatin"},{"issue":"15","key":"10.1016\/j.pharmthera.2023.108436_bb0160","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1128\/MCB.01776-08","article-title":"Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis","volume":"29","author":"Coward","year":"2009","journal-title":"Molecular and Cellular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1165\/rcmb.2020-0360OC","article-title":"Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation","volume":"64","author":"Cui","year":"2021","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108436_bb0170","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High-dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demedts","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0175","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non-small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis","volume":"5","author":"Desai","year":"2018","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"4\u20135","key":"10.1016\/j.pharmthera.2023.108436_bb0185","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1159\/000322342","article-title":"Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice","volume":"26","author":"Dhami","year":"2010","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0190","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nature Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127771","article-title":"Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis","volume":"10","author":"Donahoe","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.stem.2016.10.004","article-title":"Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis","volume":"20","author":"El Agha","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0205","doi-asserted-by":"crossref","first-page":"L313","DOI":"10.1152\/ajplung.00434.2002","article-title":"Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung","volume":"285","author":"Endo","year":"2003","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"suppl_A","key":"10.1016\/j.pharmthera.2023.108436_bb0210","doi-asserted-by":"crossref","first-page":"A21","DOI":"10.1093\/eurheartj\/sup001","article-title":"Safety and tolerability of beta-blockers: prejudices and reality","volume":"11","author":"Erdmann","year":"2009","journal-title":"European Heart Journal Supplements"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0215","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1183\/09031936.98.11030706","article-title":"Predictive value of response to treatment of T-lymphocyte subpopulations in idiopathic pulmonary fibrosis","volume":"11","author":"Fireman","year":"1998","journal-title":"The European Respiratory Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/rcmb.2017-0238OC","article-title":"Glutaminolysis promotes collagen translation and stability via alpha-ketoglutarate-mediated mTOR activation and proline hydroxylation","volume":"58","author":"Ge","year":"2018","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0225","article-title":"Fatty acid metabolism and idiopathic pulmonary fibrosis","volume":"12","author":"Geng","year":"2021","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0230","series-title":"Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis","first-page":"12","author":"Geng","year":"2022"},{"issue":"Suppl. 63","key":"10.1016\/j.pharmthera.2023.108436_bb0235","first-page":"PA1398","article-title":"BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: a single\/multiple ascending dose (SAD\/MAD) phase 1 study","volume":"54","author":"Giridhar","year":"2019","journal-title":"European Respiratory Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0240","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s12325-018-0756-3","article-title":"Anti-Anginal effectiveness and tolerability of trimetazidine modified release 80 mg once daily in stable angina patients in real-world practice","volume":"35","author":"Glezer","year":"2018","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0245","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/jcp.29138","article-title":"S1PR3 deficiency alleviates radiation-induced pulmonary fibrosis through the regulation of epithelial-mesenchymal transition by targeting miR-495-3p","volume":"235","author":"Gong","year":"2020","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trsl.2017.09.005","article-title":"Reactive oxygen species as signaling molecules in the development of lung fibrosis","volume":"190","author":"Gonzalez-Gonzalez","year":"2017","journal-title":"Translational Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1165\/rcmb.2016-0186OC","article-title":"Targeting hypoxia-inducible factor-1alpha\/pyruvate dehydrogenase kinase 1 axis by dichloroacetate suppresses bleomycin-induced pulmonary fibrosis","volume":"58","author":"Goodwin","year":"2018","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2045\u20132322 (Electronic)","key":"10.1016\/j.pharmthera.2023.108436_bb0260","doi-asserted-by":"crossref","first-page":"41605","DOI":"10.1038\/srep41605","article-title":"Dimethyl Fumarate ameliorates pulmonary arterial hypertension and lung fibrosis by targeting multiple pathways","volume":"7","author":"Grzegorzewska","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbalip.2005.09.002","article-title":"Pulmonary surfactant function is abolished by an elevated proportion of cholesterol","volume":"1737","author":"Gunasekara","year":"2005","journal-title":"Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0270","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3803\/EnM.2020.35.1.36","article-title":"Multifaceted actions of succinate as a signaling transmitter vary with its cellular locations","volume":"35","author":"Guo","year":"2020","journal-title":"Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0275","doi-asserted-by":"crossref","first-page":"5137349","DOI":"10.1155\/2020\/5137349","article-title":"Schisandra inhibit bleomycin-induced idiopathic pulmonary fibrosis in rats via suppressing M2 macrophage polarization","volume":"2020","author":"Guo","year":"2020","journal-title":"BioMed Research International"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108436_bb0280","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1111\/febs.15693","article-title":"Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism","volume":"288","author":"Hamanaka","year":"2021","journal-title":"The FEBS Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0285","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/rcmb.2019-0008OC","article-title":"Glutamine metabolism is required for collagen protein synthesis in lung fibroblasts","volume":"61","author":"Hamanaka","year":"2019","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0290","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2005","article-title":"NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury","volume":"15","author":"Hecker","year":"2009","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0295","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02373-2021","article-title":"Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis","volume":"59","author":"Heinzelmann","year":"2022","journal-title":"The European Respiratory Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0300","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/resp.12072","article-title":"Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice","volume":"18","author":"Hirata","year":"2013","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0305","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/emboj\/18.5.1345","article-title":"TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway","volume":"18","author":"Hocevar","year":"1999","journal-title":"The EMBO Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0310","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15376510701611032","article-title":"Metabolomics in lung inflammation:a high-resolution (1)h NMR study of mice exposedto silica dust","volume":"18","author":"Hu","year":"2008","journal-title":"Toxicology Mechanisms and Methods"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-3701-2-9","article-title":"Regulation of TGF-beta receptor activity","volume":"2","author":"Huang","year":"2012","journal-title":"Cell & Bioscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062064","article-title":"Sphingosine kinase 1\/S1P signaling contributes to pulmonary fibrosis by activating Hippo\/YAP pathway and mitochondrial reactive oxygen species in lung fibroblasts","volume":"21","author":"Huang","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108436_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113332","article-title":"The potential of lonidamine in combination with chemotherapy and physical therapy in cancer treatment","volume":"12","author":"Huang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0330","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejpb.2012.11.023","article-title":"Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2","volume":"84","author":"Ivanova","year":"2013","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0962","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(24)38125-X","article-title":"Effects of Pirfenidone on Procollagen Gene Expression at the Transcriptional Level in Bleomycin Hamster Model of Lung Fibrosis","volume":"289","author":"Iyer","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0335","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1183\/09031936.00143708","article-title":"Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis","volume":"34","author":"Izumo","year":"2009","journal-title":"The European Respiratory Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0340","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1074\/jbc.M112.431973","article-title":"Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling","volume":"288","author":"Jain","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0345","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1667\/RR14620.1","article-title":"The lactate dehydrogenase inhibitor gossypol inhibits radiation-induced pulmonary fibrosis","volume":"188","author":"Judge","year":"2017","journal-title":"Radiation Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0350","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1096\/fj.201701187R","article-title":"Fatty acid synthase is required for profibrotic TGF-beta signaling","volume":"32","author":"Jung","year":"2018","journal-title":"The FASEB Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0355","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/acs.jproteome.6b00156","article-title":"Metabolic profiling regarding pathogenesis of idiopathic pulmonary fibrosis","volume":"15","author":"Kang","year":"2016","journal-title":"Journal of Proteome Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0360","article-title":"Lung-targeted delivery of dimethyl fumarate promotes the reversal of age-dependent established lung fibrosis","volume":"11","author":"Kato","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0365","doi-asserted-by":"crossref","first-page":"L92","DOI":"10.1152\/ajplung.2001.281.1.L92","article-title":"IL-12 attenuates bleomycin-induced pulmonary fibrosis","volume":"281","author":"Keane","year":"2001","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0370","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0375","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/s41467-019-10839-0","article-title":"Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis","volume":"10","author":"Kheirollahi","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111070","article-title":"Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action","volume":"207","author":"Khoury","year":"2020","journal-title":"Journal of Inorganic Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0385","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.07-1948","article-title":"Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis","volume":"133","author":"Kinder","year":"2008","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108436_bb0390","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0395","doi-asserted-by":"crossref","first-page":"L34","DOI":"10.1152\/ajplung.00007.2007","article-title":"Functional role and species-specific contribution of arginases in pulmonary fibrosis","volume":"294","author":"Kitowska","year":"2008","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0400","doi-asserted-by":"crossref","first-page":"L34","DOI":"10.1152\/ajplung.00007.2007","article-title":"Functional role and species-specific contribution of arginases in pulmonary fibrosis","volume":"294","author":"Kitowska","year":"2008","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0405","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/path.4104","article-title":"The myofibroblast matrix: implications for tissue repair and fibrosis","volume":"229","author":"Klingberg","year":"2013","journal-title":"The Journal of Pathology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108436_bb0410","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1164\/rccm.201201-0084OC","article-title":"Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-beta","volume":"186","author":"Kottmann","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"24","key":"10.1016\/j.pharmthera.2023.108436_bb0415","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.119.042791","article-title":"Targeting succinate metabolism in ischemia\/reperfusion injury","volume":"140","author":"Kula-Alwar","year":"2019","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0420","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.200611146","article-title":"Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway","volume":"178","author":"Lamouille","year":"2007","journal-title":"The Journal of Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0425","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metabolism"},{"issue":"19","key":"10.1016\/j.pharmthera.2023.108436_bb0430","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"Lederer","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.30579\/mbse.2019.2.1.1","article-title":"M1 and M2 polarization of macrophages: a mini-review","volume":"2","author":"Lee","year":"2019","journal-title":"Medical Biological Science and Engineering"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0440","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","article-title":"PPARgamma and the global map of adipogenesis and beyond","volume":"25","author":"Lefterova","year":"2014","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0445","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60311","article-title":"Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation","volume":"10","author":"Lei","year":"2021","journal-title":"Elife"},{"issue":"Suppl. 100","key":"10.1016\/j.pharmthera.2023.108436_bb0450","first-page":"14","article-title":"Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis","volume":"34","author":"Lei","year":"2016","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0455","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060789","article-title":"The roles of various prostaglandins in fibrosis: a review","volume":"11","author":"Li","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bib968","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1080\/21655979.2022.2036913","article-title":"Nintedanib ameliorates oxidized low-density lipoprotein -induced inflammation and cellular senescence in vascular endothelial cells","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0460","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.toxlet.2019.06.006","article-title":"2,3'4,4',5-pentachlorobiphenyl induces hepatocellular carcinoma cell proliferation through pyruvate kinase M2-dependent glycolysis","volume":"313","author":"Liang","year":"2019","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109230","article-title":"New therapeutic strategies for IPF: Based on the \"phagocytosis-secretion-immunization\" network regulation mechanism of pulmonary macrophages","volume":"118","author":"Liu","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0470","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","article-title":"Targeting amino acid metabolism for cancer therapy","volume":"22","author":"Lukey","year":"2017","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0965","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10020-020-00173-3","article-title":"Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt\/GSK-3\u03b2\/\u03b2-catenin and TGF-\u03b21\/Smad2\/3 signaling pathways","volume":"26","author":"Lv","year":"2020","journal-title":"Molecular Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108436_bb0475","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial","volume":"6","author":"Maher","year":"2018","journal-title":"The Lancet Respiratory Medicine"},{"issue":"34","key":"10.1016\/j.pharmthera.2023.108436_bb0480","doi-asserted-by":"crossref","first-page":"20712","DOI":"10.1074\/jbc.R115.662627","article-title":"Protein hydroxylation catalyzed by 2-oxoglutarate-dependent oxygenases","volume":"290","author":"Markolovic","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0485","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0490","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/med.21551","article-title":"Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials","volume":"39","author":"Matralis","year":"2019","journal-title":"Medicinal Research Reviews"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0495","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1165\/rcmb.2017-0321TR","article-title":"Pseudomonas aeruginosa biofilms: host response and clinical implications in lung infections","volume":"58","author":"Maurice","year":"2018","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0500","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000205","article-title":"Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1","volume":"2","author":"McCarty","year":"2015","journal-title":"Open Heart"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108436_bb0505","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1128\/MCB.02419-05","article-title":"Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development","volume":"26","author":"van Meeteren","year":"2006","journal-title":"Molecular and Cellular Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0510","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0515","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/thoraxjnl-2011-200026","article-title":"Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition","volume":"67","author":"Milara","year":"2012","journal-title":"Thorax"},{"issue":"7699","key":"10.1016\/j.pharmthera.2023.108436_bb0520","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0525","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0530","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fimmu.2017.00296","article-title":"Sphingosine 1-phosphate: a novel target for lung disorders","volume":"8","author":"Mohammed","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0535","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40139-013-0017-8","article-title":"Regulation and relevance of myofibroblast responses in idiopathic pulmonary fibrosis","volume":"1","author":"Moore","year":"2013","journal-title":"Current Pathobiology Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0540","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1165\/rcmb.2006-0121OC","article-title":"Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis","volume":"35","author":"Mora","year":"2006","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0545","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2165\/00044011-200525090-00003","article-title":"Safety and tolerability of acarbose in the treatment of Type 1 and Type 2 diabetes mellitus","volume":"25","author":"Neuser","year":"2005","journal-title":"Clinical Drug Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0550","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12931-021-01866-x","article-title":"Dysfunctional lactate metabolism in human alveolar type II cells from idiopathic pulmonary fibrosis lung explant tissue","volume":"22","author":"Newton","year":"2021","journal-title":"Respiratory Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0555","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1753425919861774","article-title":"Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages","volume":"25","author":"Nie","year":"2019","journal-title":"Innate Immunity"},{"issue":"53","key":"10.1016\/j.pharmthera.2023.108436_bb0560","doi-asserted-by":"crossref","first-page":"27239","DOI":"10.1074\/jbc.M116.756247","article-title":"Transforming Growth Factor (TGF)-beta promotes de novo serine synthesis for collagen production","volume":"291","author":"Nigdelioglu","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0565","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmed.2018.00180","article-title":"Autotaxin in pathophysiology and pulmonary fibrosis","volume":"5","author":"Ninou","year":"2018","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0570","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/13993003.00026-2015","article-title":"Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials","volume":"47","author":"Noble","year":"2016","journal-title":"The European Respiratory Journal"},{"issue":"52","key":"10.1016\/j.pharmthera.2023.108436_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc1884","article-title":"Itaconate controls the severity of pulmonary fibrosis","volume":"5","author":"Ogger","year":"2020","journal-title":"Science Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0580","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1165\/rcmb.2020-0143OC","article-title":"TGF-beta promotes metabolic reprogramming in lung fibroblasts via mTORC1-dependent ATF4 activation","volume":"63","author":"O\u2019Leary","year":"2020","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0585","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.7150\/thno.48152","article-title":"Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis","volume":"11","author":"Pan","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0590","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1038\/s41598-021-81591-z","article-title":"Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses","volume":"11","author":"Park","year":"2021","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0595","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1194\/jlr.M035352","article-title":"CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury","volume":"54","author":"Parks","year":"2013","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0600","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148548","article-title":"The role of itaconate in host defense and inflammation","volume":"132","author":"Peace","year":"2022","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0605","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1194\/jlr.R046391","article-title":"Autotaxin: structure-function and signaling","volume":"55","author":"Perrakis","year":"2014","journal-title":"Journal of Lipid Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0610","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/ajrccm.165.2.2104050","article-title":"Protection from pulmonary fibrosis in leukotriene-deficient mice","volume":"165","author":"Peters-Golden","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0615","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0967","doi-asserted-by":"crossref","unstructured":"Plataki M, Cho SJ, Harris RM, Huang HR, Yun HS, Schiffer KT, Stout-Delgado HW (2019). Mitochondrial Dysfunction in Aged Macrophages and Lung during Primary Streptococcus pneumoniae Infection is Improved with Pirfenidone. Scientific Reports, 30;9(1):971.","DOI":"10.1038\/s41598-018-37438-1"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0620","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1054\/jcaf.2002.130238","article-title":"Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure","volume":"8","author":"Podbregar","year":"2002","journal-title":"Journal of Cardiac Failure"},{"issue":"87","key":"10.1016\/j.pharmthera.2023.108436_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001725","article-title":"The role of dimethylarginine dimethylaminohydrolase in idiopathic pulmonary fibrosis","volume":"3","author":"Pullamsetti","year":"2011","journal-title":"Science Translational Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108436_bb0630","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41589-019-0323-5","article-title":"S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate","volume":"15","author":"Qin","year":"2019","journal-title":"Nature Chemical Biology"},{"issue":"21","key":"10.1016\/j.pharmthera.2023.108436_bb0635","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2023.108436_bb0640","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0891-5849(99)00035-0","article-title":"Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis","volume":"27","author":"Rahman","year":"1999","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0645","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cca.2014.06.004","article-title":"Antioxidants and human diseases","volume":"436","author":"Rajendran","year":"2014","journal-title":"Clinica Chimica Acta"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108436_bb0650","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0655","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0660","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108436_bb0665","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0670","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12931-018-0714-2","article-title":"Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC","volume":"19","author":"Rindlisbacher","year":"2018","journal-title":"Respiratory Research"},{"issue":"2 Suppl 4","key":"10.1016\/j.pharmthera.2023.108436_bb0675","first-page":"18","article-title":"Toxicity and clinical tolerance of lonidamine","volume":"18","author":"Robustelli Della Cuna","year":"1991","journal-title":"Seminars in Oncology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0680","doi-asserted-by":"crossref","first-page":"C689","DOI":"10.1152\/ajpcell.00586.2020","article-title":"Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids","volume":"320","author":"Roque","year":"2021","journal-title":"American Journal of Physiology. Cell Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0685","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","article-title":"Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages","volume":"34","author":"Runtsch","year":"2022","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0690","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1165\/rcmb.2019-0358OC","article-title":"Air space distension precedes spontaneous fibrotic remodeling and impaired cholesterol metabolism in the absence of surfactant protein C","volume":"62","author":"Ruwisch","year":"2020","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0695","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s42255-018-0014-7","article-title":"Coupling Krebs cycle metabolites to signalling in immunity and cancer","volume":"1","author":"Ryan","year":"2019","journal-title":"Nature Metabolism"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0700","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1164\/rccm.201612-2480OC","article-title":"Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis","volume":"196","author":"Ryu","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0705","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000073718","article-title":"Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro","volume":"132","author":"Saito","year":"2003","journal-title":"International Archives of Allergy and Immunology"},{"issue":"Suppl. 14","key":"10.1016\/j.pharmthera.2023.108436_bb0710","doi-asserted-by":"crossref","first-page":"S1740","DOI":"10.21037\/jtd.2019.04.62","article-title":"Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)","volume":"11","author":"Saito","year":"2019","journal-title":"Journal of Thoracic Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0715","doi-asserted-by":"crossref","first-page":"L175","DOI":"10.1152\/ajplung.00551.2017","article-title":"HDAC8 inhibition ameliorates pulmonary fibrosis","volume":"316","author":"Saito","year":"2019","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0720","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1183\/09031936.00095113","article-title":"Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice","volume":"43","author":"Sanders","year":"2014","journal-title":"The European Respiratory Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0725","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12931-019-1058-2","article-title":"Human lung fibroblast-to-myofibroblast transformation is not driven by an LDH5-dependent metabolic shift towards aerobic glycolysis","volume":"20","author":"Schruf","year":"2019","journal-title":"Respiratory Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108436_bb0730","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103334","article-title":"Proline biosynthesis is a vent for TGFbeta-induced mitochondrial redox stress","volume":"39","author":"Schworer","year":"2020","journal-title":"The EMBO Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0735","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"issue":"582","key":"10.1016\/j.pharmthera.2023.108436_bb0740","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav3048","article-title":"mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-beta(1)-induced collagen biosynthesis","volume":"12","author":"Selvarajah","year":"2019","journal-title":"Science Signaling"},{"issue":"38","key":"10.1016\/j.pharmthera.2023.108436_bb0745","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","article-title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1","volume":"269","author":"Semenza","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108436_bb0750","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1128\/MCB.01476-09","article-title":"MOF and Histone H4 acetylation at Lysine 16 are critical for DNA damage response and double-strand break repair","volume":"30","author":"Sharma","year":"2010","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0755","first-page":"49","article-title":"The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis","volume":"120","author":"Strieter","year":"2009","journal-title":"Transactions of the American Clinical and Climatological Association"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0963","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-022-01269-5","article-title":"A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors","volume":"15","author":"Su","year":"2022","journal-title":"Journal of Hematology & Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0961","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2017","article-title":"Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI","volume":"52","author":"Sun","year":"2018","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0760","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","article-title":"A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model","volume":"160","author":"Swaney","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"Tager","year":"2008","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0770","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jcmm.12178","article-title":"Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts","volume":"18","author":"Tang","year":"2014","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0775","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1172\/JCI94152","article-title":"EMC3 coordinates surfactant protein and lipid homeostasis required for respiration","volume":"127","author":"Tang","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0780","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1183\/09031936.00005209","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"35","author":"Taniguchi","year":"2010","journal-title":"The European Respiratory Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108436_bb0785","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.0000100443.09293.4F","article-title":"Reactive oxygen species in the vasculature: molecular and cellular mechanisms","volume":"42","author":"Taniyama","year":"2003","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0790","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/bph.13532","article-title":"Therapeutic potential of NADPH oxidase 1\/4 inhibitors","volume":"174","author":"Teixeira","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0795","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.12.003","article-title":"HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction","volume":"39","author":"Tian","year":"2019","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0800","doi-asserted-by":"crossref","first-page":"106361","DOI":"10.1016\/j.biocel.2022.106361","article-title":"Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: a review","volume":"155","author":"Tian","year":"2023","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0805","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12890-020-1103-4","article-title":"Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort","volume":"20","author":"Todd","year":"2020","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0810","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/JIR.S40673","article-title":"Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis","volume":"6","author":"Todd","year":"2013","journal-title":"Journal of Inflammation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21718-y","article-title":"Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formation","volume":"12","author":"Tomlinson","year":"2021","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0820","doi-asserted-by":"crossref","first-page":"588","DOI":"10.5606\/tgkdc.dergisi.2019.15149","article-title":"Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin-induced pulmonary fibrosis","volume":"26","author":"Topalo\u011flu","year":"2018","journal-title":"Turk Gogus Kalp Damar Cerrahisi Dergisi"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108436_bb0825","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1164\/rccm.200705-683OC","article-title":"Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis","volume":"176","author":"Tzouvelekis","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108436_bb0830","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1089\/ars.2019.7742","article-title":"Redox imbalance in idiopathic pulmonary fibrosis: a role for oxidant cross-talk between NADPH oxidase enzymes and mitochondria","volume":"31","author":"Veith","year":"2019","journal-title":"Antioxidants & Redox Signaling"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0835","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.4049\/jimmunol.1900039","article-title":"Epithelial expression of an interstitial lung disease-associated mutation in surfactant protein-C modulates recruitment and activation of key myeloid cell populations in mice","volume":"202","author":"Venosa","year":"2019","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0840","doi-asserted-by":"crossref","first-page":"L117","DOI":"10.1152\/ajplung.00218.2009","article-title":"Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury","volume":"298","author":"Vockeroth","year":"2010","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108436_bb0845","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ymthe.2021.02.023","article-title":"Arginine is a key player in fibroblasts during the course of IPF development","volume":"29","author":"Wang","year":"2021","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0850","doi-asserted-by":"crossref","first-page":"102082","DOI":"10.1016\/j.redox.2021.102082","article-title":"Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis","volume":"46","author":"Wang","year":"2021","journal-title":"Redox Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108436_bb0855","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1164\/rccm.202105-1284OC","article-title":"Notch1 induces defective epithelial surfactant processing and pulmonary fibrosis","volume":"207","author":"Wasnick","year":"2023","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0860","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049105","article-title":"Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice","volume":"15","author":"Weckerle","year":"2022","journal-title":"Disease Models & Mechanisms"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0865","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049105","article-title":"Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice","volume":"15","author":"Weckerle","year":"2022","journal-title":"Disease Models & Mechanisms"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0870","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1111\/j.1067-1927.2005.130117ac.x","article-title":"Mechanical Stress Induces TGF\u03b21 activation in myofibroblast culture","volume":"13","author":"Wipff","year":"2005","journal-title":"Wound Repair and Regeneration"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0875","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5114\/ceji.2016.60990","article-title":"Macrophage polarization in interstitial lung diseases","volume":"41","author":"Wojtan","year":"2016","journal-title":"Central European Journal of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0880","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0885","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathol-012513-104706","article-title":"Pathogenesis of idiopathic pulmonary fibrosis","volume":"9","author":"Wolters","year":"2014","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0890","series-title":"Differentiating Characteristics of Cudetaxestat (BLD-0409), a Non-Competitive Autotaxin Inhibitor Under Development to Treat Idiopathic Pulmonary Fibrosis. D29. Mechanisms In Lung Injury, Repair, And Fibrosis","first-page":"A5234","author":"Wong","year":"2022"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2015.078","article-title":"Alpha-ketoglutarate: physiological functions and applications","volume":"24","author":"Wu","year":"2016","journal-title":"Biomolecules & Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0900","doi-asserted-by":"crossref","first-page":"5265616","DOI":"10.1155\/2022\/5265616","article-title":"Contribution of adiponectin\/carnitine palmityl transferase 1A-mediated fatty acid metabolism during the development of idiopathic pulmonary fibrosis","volume":"2022","author":"Wu","year":"2022","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0905","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0954-6111(98)90118-4","article-title":"Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis","volume":"92","author":"Xaubet","year":"1998","journal-title":"Respiratory Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108436_bb0910","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","article-title":"Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis","volume":"192","author":"Xie","year":"2015","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108436_bb0964","doi-asserted-by":"crossref","first-page":"110063","DOI":"10.1016\/j.celrep.2021.110063","article-title":"Lysophosphatidic acid shifts metabolic and transcriptional landscapes to induce a distinct cellular state in human pluripotent stem cells","volume":"37","author":"Xu","year":"2021","journal-title":"Cell Rep"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108436_bb0915","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90558","article-title":"Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis","volume":"1","author":"Xu","year":"2016","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108436_bb0920","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1016\/S0021-9258(17)36823-0","article-title":"Two different signal transduction pathways can be activated by transforming growth factor beta 1 in epithelial cells","volume":"269","author":"Yan","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0925","doi-asserted-by":"crossref","first-page":"587913","DOI":"10.3389\/fimmu.2020.587913","article-title":"Lactate suppresses macrophage pro-inflammatory response to lps stimulation by inhibition of YAP and NF-kappaB activation via GPR81-mediated signaling","volume":"11","author":"Yang","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"612","key":"10.1016\/j.pharmthera.2023.108436_bb0930","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aax4067","article-title":"Hexokinase 2 couples glycolysis with the profibrotic actions of TGF-\u03b2","volume":"12","author":"Yin","year":"2019","journal-title":"Science Signaling"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108436_bb0966","doi-asserted-by":"crossref","first-page":"8662","DOI":"10.1111\/jcmm.16821","article-title":"Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-\u03b21\/Smad3 pathway","volume":"25","author":"Ying","year":"2021","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0935","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nm.4447","article-title":"Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function","volume":"24","author":"Yu","year":"2018","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108436_bb0940","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1194\/jlr.R046458","article-title":"LPA receptor signaling: pharmacology, physiology, and pathophysiology","volume":"55","author":"Yung","year":"2014","journal-title":"Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108436_bb0945","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1194\/jlr.M074955","article-title":"Lipidomic characterization and localization of phospholipids in the human lung","volume":"58","author":"Zemski Berry","year":"2017","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2023.108436_bb0950","series-title":"Tianlongkechuanling Inhibits Pulmonary Fibrosis Through Down-Regulation of Arginase-Ornithine Pathway","first-page":"12","author":"Zhang","year":"2021"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108436_bb0955","doi-asserted-by":"crossref","first-page":"530","DOI":"10.7150\/thno.62760","article-title":"Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108436_bb0960","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2017-000183","article-title":"Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study","volume":"4","author":"Zhao","year":"2017","journal-title":"BMJ Open Respiratory Research"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:33:06Z","timestamp":1759012386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":200,"alternative-id":["S0163725823001006"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108436","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of metabolic pathways in pulmonary fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108436"}}